Price
No data yet.
Social Signal Score
20
5d
21
1 mentions
—
30d
20
1 mentions
—
60d
20
1 mentions
—
90d
20
1 mentions
—
news: 1
Company Profile
- CEO
- Aleksandrs Zhavoronkov
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 333
- Beta
- 2.41
- Country
- HK
Quote
Day Range
—
52-Week Range
—
Volume
—
Market Cap
—
50-Day Avg
—
200-Day Avg
—
Prev Close
—
Open
—
Valuation & Ratios
P/E Ratio
—
EPS
—
P/B Ratio
—
P/S Ratio
—
Debt/Equity
—
Current Ratio
—
Dividend Yield
—
Gross Margin
—
Returns & Efficiency
Return on Equity
—
Return on Assets
—
FCF Yield
—
EV/EBITDA
—
Valuation
3696.HKhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
70Sep 9Sep 9
Social Signal Score
20
5d
21
1 mentions
—
30d
20
1 mentions
—
60d
20
1 mentions
—
90d
20
1 mentions
—
news: 1
Mentions (1)
- Newsprnewswire.com·6h ago·Negative
Insilico Medicine Doses First Patient in GENESIS-IPF-3, the World's First Phase III Trial of a Generative AI-Driven Innovative Drug /PRNewswire/ -- Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced that it has dosed
View source ↗